Etoposide and graft versus host disease Patient Reports February 12, 2012

Etoposide Side Effects Report #5705411-X
Etoposide side effect was reported by a Health Professional from GERMANY on Apr 09, 2008. Male patient, child 6 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Etoposide. After drug was administered, patient experienced the following side effects: graft versus host disease, malignant neoplasm progression. Etoposide dosage: unknown. Patient died.

Etoposide Side Effects Report #5703849-8
Etoposide side effect was reported by a Health Professional from GERMANY on Apr 09, 2008. Male patient, child 5 years of age, was diagnosed with bone marrow conditioning regimen, immunosuppression and was treated with Etoposide. After drug was administered, patient experienced the following side effects: convulsion, graft versus host disease, reversible posterior leukoencephalopathy syndrome. Etoposide dosage: unknown. During the same period patient was treated with THYMOGLOBULIN, TACROLIMUS, CYCLOSPORINE, METHOTREXATE. Patient recovered.

Etoposide Side Effects Report #5703962-5
Etoposide side effect was reported by a Health Professional from GERMANY on Apr 09, 2008. Male patient, 14 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Etoposide. After drug was administered, patient experienced the following side effects: graft versus host disease, malignant neoplasm progression. Etoposide dosage: unknown. During the same period patient was treated with THYMOGLOBULIN. Patient died.

Etoposide Side Effects Report #5704080-2
Etoposide side effect was reported by a Health Professional from GERMANY on Apr 09, 2008. Male patient, child 11 years of age, was diagnosed with bone marrow conditioning regimen, immunosuppression and was treated with Etoposide. After drug was administered, patient experienced the following side effects: graft versus host disease, herpes zoster. Etoposide dosage: unknown. During the same period patient was treated with THYMOGLOBULIN, CYCLOSPORINE, METHOTREXATE. Patient recovered.


Etoposide Side Effects Report #5704084-X
Etoposide side effect was reported by a Health Professional from GERMANY on Apr 09, 2008. Male patient, child 11 years of age, was diagnosed with bone marrow conditioning regimen, immunosuppression and was treated with Etoposide. After drug was administered, patient experienced the following side effects: aspergillosis, graft versus host disease, neutropenia. Etoposide dosage: unknown. During the same period patient was treated with THYMOGLOBULIN, CYCLOSPORINE, METHOTREXATE. Patient died.

Etoposide Side Effects Report #5705384-X
Etoposide side effect was reported by a Health Professional from GERMANY on Apr 09, 2008. Female patient, child 11 years of age, was diagnosed with bone marrow conditioning regimen, immunosuppression and was treated with Etoposide. After drug was administered, patient experienced the following side effects: encephalitis cytomegalovirus, graft versus host disease, malignant neoplasm progression. Etoposide dosage: unknown. During the same period patient was treated with ANTILYMPHOCYTE IMMUNOGLOBULIN, CYCLOSPORINE, METHOTREXATE. Patient died.

Etoposide Side Effects Report #4707395-X
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on July 05, 2005. Male patient, weighting 193.3 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: confusional state, dyspnoea, graft versus host disease, hypoxia, obliterative bronchiolitis, tachycardia. Etoposide dosage: 100MG/M2 IV OVER 1 HR ON DAY (-3).. During the same period patient was treated with ALLOGINIC BONE MARROW CELLS, ALFA. Patient recovered.

Etoposide Side Effects Report #4707864-2
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on July 05, 2005. Male patient, weighting 193.3 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: confusional state, dyspnoea, graft versus host disease, hypoxia, obliterative bronchiolitis, post procedural complication, tachycardia. Etoposide dosage: 100 MG/M2 IV OVER 1 HR ON DAY (-3).. During the same period patient was treated with ALLOGENIC BONE MARROW CELLS, ALFA, IRRADIATION. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5702391-8
Etoposide side effect was reported by a Health Professional from GERMANY on Apr 07, 2008. Male patient, child 5 years of age, was treated with Etoposide. After drug was administered, patient experienced the following side effects: convulsion, graft versus host disease, reversible posterior leukoencephalopathy syndrome. Etoposide dosage: unknown. During the same period patient was treated with THYMOGLOBULIN, TACROLIMUS. Patient recovered.


Etoposide Side Effects Report #5834121-3
Etoposide side effect was reported by a Health Professional from UNITED STATES on July 30, 2008. Male patient, 20 years of age, was treated with Etoposide. After drug was administered, patient experienced the following side effects: graft versus host disease, guillain-barre syndrome . Etoposide dosage: unknown. During the same period patient was treated with BUSULFAN. Patient recovered.

Etoposide Side Effects Report #5224676-4
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2007. Male patient, weighting 185.4 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, confusional state, convulsion, cytomegalovirus infection , graft versus host disease, hydrocephalus , meningitis , pneumonia . Etoposide dosage: 4968 MG. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5318915-9
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on May 04, 2007. Male patient, weighting 185.4 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, confusional state, convulsion, cytomegalovirus infection , graft versus host disease, hydrocephalus , immune system disorder, meningitis . Etoposide dosage: 4968 MG. Patient was hospitalized. Patient died on 04/14/2007.